Year-3 Checkpoint Card for Long-Term ADHD Medication

A point-of-care shared-decision card used at the 3-year mark of ADHD medication treatment that lays the patient's symptom-control benefits against their quantified cardiovascular risk trajectory — which the new evidence shows climbs steeply through year 3 then plateaus — producing a documented continue, dose-reduce, or reassess decision.